Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lachmann

Showing results (281-290 of 426) with videos related to

Pageof 43
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 13, 2021
Renal transplant outcomes in amyloidosisSteven Law, Oliver Cohen, Helen J Lachmann, et al.
QJM : Monthly Journal of the Association of Physicians|April 29, 2000
The genetic basis of autosomal dominant familial Mediterranean feverD R Booth, J D Gillmore, H J Lachmann, et al.
Clinical and Experimental Rheumatology|October 8, 2021
Canakinumab improves patient-reported outcomes in children and adults with autoinflammatory recurrent fever syndromes: results from the CLUSTER trialHelen J Lachmann, Bernard Lauwerys, Paivi Miettunen, et al.
British Journal of Haematology|April 26, 2002
Translocations of 14q32 and deletions of 13q14 are common chromosomal abnormalities in systemic amyloidosisChristine J Harrison, Helen Mazzullo, Fiona M Ross, et al.
The New England Journal of Medicine|June 5, 2009
Use of canakinumab in the cryopyrin-associated periodic syndromeHelen J Lachmann, Isabelle Kone-Paut, Jasmin B Kuemmerle-Deschner, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 17, 2014
Brief Report: whole-exome sequencing revealing somatic NLRP3 mosaicism in a patient with chronic infantile neurologic, cutaneous, articular syndromeEbun Omoyinmi, Sónia Melo Gomes, Ariane Standing, et al.
Haematologica|August 22, 2015
Clinical profile and treatment outcome of older (>75 years) patients with systemic AL amyloidosisSajitha Sachchithanantham, Mark Offer, Christopher Venner, et al.
Arthritis Research & Therapy|February 21, 2013
Clinical characteristics in subjects with NLRP3 V198M diagnosed at a single UK center and a review of the literatureDorota M Rowczenio, Hadija Trojer, Tonia Russell, et al.
Digestive Diseases and Sciences|February 2, 2013
Inflammatory bowel disease and systemic AA amyloidosisPrayman T Sattianayagam, Julian D Gillmore, Jennifer H Pinney, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1985
Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activationG D Ross, W J Yount, M J Walport, et al.
Pageof 43

Showing results (281-290 of 426) with videos related to

Sort By:
Pageof 43
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 13, 2021
Renal transplant outcomes in amyloidosisSteven Law, Oliver Cohen, Helen J Lachmann, et al.
QJM : Monthly Journal of the Association of Physicians|April 29, 2000
The genetic basis of autosomal dominant familial Mediterranean feverD R Booth, J D Gillmore, H J Lachmann, et al.
Clinical and Experimental Rheumatology|October 8, 2021
Canakinumab improves patient-reported outcomes in children and adults with autoinflammatory recurrent fever syndromes: results from the CLUSTER trialHelen J Lachmann, Bernard Lauwerys, Paivi Miettunen, et al.
British Journal of Haematology|April 26, 2002
Translocations of 14q32 and deletions of 13q14 are common chromosomal abnormalities in systemic amyloidosisChristine J Harrison, Helen Mazzullo, Fiona M Ross, et al.
The New England Journal of Medicine|June 5, 2009
Use of canakinumab in the cryopyrin-associated periodic syndromeHelen J Lachmann, Isabelle Kone-Paut, Jasmin B Kuemmerle-Deschner, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 17, 2014
Brief Report: whole-exome sequencing revealing somatic NLRP3 mosaicism in a patient with chronic infantile neurologic, cutaneous, articular syndromeEbun Omoyinmi, Sónia Melo Gomes, Ariane Standing, et al.
Haematologica|August 22, 2015
Clinical profile and treatment outcome of older (>75 years) patients with systemic AL amyloidosisSajitha Sachchithanantham, Mark Offer, Christopher Venner, et al.
Arthritis Research & Therapy|February 21, 2013
Clinical characteristics in subjects with NLRP3 V198M diagnosed at a single UK center and a review of the literatureDorota M Rowczenio, Hadija Trojer, Tonia Russell, et al.
Digestive Diseases and Sciences|February 2, 2013
Inflammatory bowel disease and systemic AA amyloidosisPrayman T Sattianayagam, Julian D Gillmore, Jennifer H Pinney, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1985
Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activationG D Ross, W J Yount, M J Walport, et al.
Pageof 43